Evaluating Neurofilament Light Chain as a Biomarker to Measure Therapeutic Effect on ALS Disease Progression
Time: 8:30 am
day: Day Two AM
Details:
• Exploring the capabilities of neurofilament light chain, poly(GP), poly(GA) and poly(GA) as biomarkers for ALS diagnosis
• Highlighting discrepancies in neurofilament light changes in recent ALS clinical trials
• Discussing serum vs CSF measurements to measure impact on disease
